Derrick Lau

Derrick Lau

Auto-generated profile, based on publicly available information

Derrick Lau

EMBL Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, UNSW Sydney, Sydney, New South Wales 2052, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
ALAndré D. G. Leitão
André D. G. Leitão
PRPaulina Rudolffi-Soto
Paulina Rudolffi-Soto
ACAlexandre Chappard
Alexandre Chappard
ABAkshay Bhumkar
Akshay Bhumkar
DLDerrick Lau
Derrick Lau
Emma SiereckiEmma Sierecki
Emma Sierecki
The aggregation of alpha-synuclein (α-SYN) follows a cascade of oligomeric, prefibrillar and fibrillar forms, culminating in the formation of Lewy Bodies (LB), the pathological hallmarks of Parkinson’s Disease. Although LB contain over 70 proteins, the potential for interactions along the aggregation pathway of α-SYN is unknown. Here we propose a map of interactions of 65 proteins against different species of α-SYN. We measured binding to monomeric α-SYN using AlphaScreen, a sensitive nano-bead luminescence assay for detection of protein interactions. To access oligomeric species, we used the pathological mutants of α-SYN (A30P, G51D and A53T) which form oligomers with distinct properties. Finally, we generated amyloid fibrils from recombinant α-SYN. Binding to oligomers and fibrils was measured by two-color coincidence detection (TCCD) on a single molecule spectroscopy setup. Overall, we demonstrate that LB components are recruited to specific steps in the aggregation of α-SYN, uncovering future targets to modulate aggregation in synucleinopathies.

4 September 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
DLDerrick Lau
Derrick Lau
JWJames C. Walsh
James C. Walsh
WPWang Peng
Wang Peng
VSVaibhav B. Shah
Vaibhav B. Shah
STStuart Turville
Stuart Turville
TBTill Boecking
Till Boecking

14 March 2022 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
DLDerrick Lau
Derrick Lau
CMChloé Magnan
Chloé Magnan
KHKathryn Hill
Kathryn Hill
ACAntony Cooper
Antony Cooper
YGYann Gambin
Yann Gambin
Emma SiereckiEmma Sierecki
Emma Sierecki
The quantification of α-synuclein aggregates has emerged as a promising biomarker for synucleinopathies. Assays that amplify and detect such aggregates have revealed the presence of seeding-competent species in biosamples of patients diagnosed with Parkinson’s disease. However, multiple species, such as oligomers and amyloid fibrils, are formed during the aggregation of α-synuclein; these species are likely to coexist in biological samples, and thus it remains unclear which species(s) are contributing to the signal detected in seeding assays. To identify individual contributions to the amplification process, recombinant oligomers and preformed fibrils were produced and purified to characterize their individual biochemical and seeding potential. Here, we used single molecule spectroscopy to track the formation and purification of oligomers and fibrils at the single particle level and compare their respective seeding potential in an amplification assay. Single molecule detection validates that size-exclusion chromatography efficiently separates oligomers from fibrils. Oligomers were found to be seeding-competent, but our results reveal that their seeding behavior is very different compared to that of preformed fibrils, in our amplification assay. Overall, our data suggest that even a low number of preformed fibrils present in biosamples is likely to dominate the response in seeding assays.

26 March 2020 in Langmuir
Verified
Journal Article
Closed access
DLDerrick Lau
Derrick Lau
JWJames C. Walsh
James C. Walsh
AMAmir Mousapasandi
Amir Mousapasandi
NANick Ariotti
Nick Ariotti
VSVaibhav B. Shah
Vaibhav B. Shah
TBTill Boecking
Till Boecking

28 August 2024 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
DLDerrick Lau
Derrick Lau
YTYuan Tang
Yuan Tang
VKVijaya Kenche
Vijaya Kenche
TCThomas Copie
Thomas Copie
DKDaryan Kempe
Daryan Kempe
Emma SiereckiEmma Sierecki
Emma Sierecki

16 February 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
DLDerrick Lau
Derrick Lau
JWJames C. Walsh
James C. Walsh
CDClaire F. Dickson
Claire F. Dickson
ATAndrew Tuckwell
Andrew Tuckwell
JSJeffrey H. Stear
Jeffrey H. Stear
DJDavid A. Jacques
David A. Jacques